Anzeige
Mehr »
Donnerstag, 26.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40M9K | ISIN: US10501E3009 | Ticker-Symbol: GHD
Lang & Schwarz
26.06.25 | 07:00
1,050 Euro
-100,00 % -1,050
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BRAINSTORM CELL THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
BRAINSTORM CELL THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0401,06007:00

Aktuelle News zur BRAINSTORM CELL THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBRAINSTORM CELL THERAPEUTICS INC. - 8-K, Current Report1
16.06.BRAINSTORM CELL THERAPEUTICS INC. - 8-K, Current Report2
16.06.BrainStorm Cell Therapeutics Inc.: BrainStorm Announces New Survival Data from Expanded Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn98NEW YORK, June 16, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative...
► Artikel lesen
19.05.Brainstorm Cell Therapeutics outlines imminent Phase 3b ALS trial launch following FDA clearance and expanded manufacturing plans2
19.05.BrainStorm Cell Therapeutics Inc.: BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn for ALS187Investor call and webcast scheduled for today at 8:30 a.m. ET NEW YORK, May 19, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading...
► Artikel lesen
15.05.BRAINSTORM CELL THERAPEUTICS INC. - 10-Q, Quarterly Report1
15.05.BRAINSTORM CELL THERAPEUTICS INC. - 8-K, Current Report1
15.05.BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update287Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc....
► Artikel lesen
BRAINSTORM CELL THERAPEUTICS Aktie jetzt für 0€ handeln
14.05.BrainStorm Cell Therapeutics Q1 2025 Earnings Preview1
21.04.BRAINSTORM CELL THERAPEUTICS INC. - 8-K, Current Report3
10.04.BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn in ALS309NEW YORK, April 10, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies...
► Artikel lesen
31.03.BRAINSTORM CELL THERAPEUTICS INC. - 10-K, Annual Report3
31.03.BrainStorm Cell Therapeutics GAAP EPS of -$2.313
31.03.BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update289Conference call and webcast at 8:30 a.m. Eastern Time today NEW YORK, March 31, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading...
► Artikel lesen
28.03.BrainStorm Cell Therapeutics Q4 2024 Earnings Preview2
28.03.A Preview Of Brainstorm Cell's Earnings2
27.03.BRAINSTORM CELL THERAPEUTICS INC. - 8-K, Current Report1
26.03.BrainStorm Cell Therapeutics receives Nasdaq compliance extension3
15.01.BRAINSTORM CELL THERAPEUTICS INC. - 8-K, Current Report-
14.11.24BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update275Conference call planned for later in Q4 2024 to provide updates on NurOwn® program NEW YORK, Nov. 14, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc....
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1